Canada Gazette, Part I, Volume 158, Number 13: GOVERNMENT NOTICES

March 30, 2024

DEPARTMENT OF CITIZENSHIP AND IMMIGRATION

FINANCIAL ADMINISTRATION ACT

Notice of biennial increase of permanent residence fees pursuant to the Immigration and Refugee Protection Regulations

Notice is hereby given that, in keeping with subsection 303(1.1) and paragraph 294(d) of the Immigration and Refugee Protection Regulations, the permanent residence fees will increase at 9:00:00 a.m. Eastern daylight time on April 30, 2024, by the cumulative percentage increase to the Consumer Price Index for Canada, published by Statistics Canada, for the two previous years, rounded to the nearest five dollars.

The current fees and the fees updated as of April 30, 2024, are listed below.

Any inquiries or comments about the updated fees can be directed to Martin Mulligan, Director, Fees, Integrated Financial Management for Passport and Business Intelligence-cost Management Division, Financial Partnership Branch, 613‑793‑8242 or IRCC.FSBFees-FraisDGSF.IRCC@cic.gc.ca.

Table 1: Comparison of current and new permanent resident fees
Program Applicants Current fees (April 2022– March 2024) New fees
(April 2024–March 2026) table a1 note 1
Right of Permanent Residence Fee Principal applicant and accompanying spouse or common-law partner $515 $575
Federal Skilled Workers, Provincial Nominee Program, Quebec Skilled Workers, Atlantic Immigration Class and most economic pilots (Rural, Agri-Food) Principal applicant $850 $950
Accompanying spouse or common-law partner $850 $950
Accompanying dependent child table a1 note 2 $230 $260
Live-in Caregiver Program and caregivers pilots (Home Child Provider Pilot and Home Support Worker Pilot) Principal applicant $570 $635
Accompanying spouse or common-law partner $570 $635
Accompanying dependent child table a1 note 2 $155 $175
Business (federal and Quebec) Principal applicant $1,625 $1,810
Accompanying spouse or common-law partner $850 $950
Accompanying dependent child table a1 note 2 $230 $260
Family reunification (spouses, partners and children; parents and grandparents; and other relatives) Sponsorship fee $75 $85
Sponsored principal applicant $490 $545
Sponsored child (principal applicant under 22 years old and not a spouse/partner) table a1 note 2 $75 $85
Accompanying spouse or common-law partner $570 $635
Accompanying dependent child table a1 note 2 $155 $175
Protected persons Principal applicant table a1 note 2 $570 $635
Accompanying spouse or common-law partner table a1 note 2 $570 $635
Accompanying dependent child table a1 note 2 $155 $175
Humanitarian and compassionate consideration / Public policy Principal applicant table a1 note 2 $570 $635
Accompanying spouse or common-law partner $570 $635
Accompanying dependent child table a1 note 2 $155 $175
Permit holders Principal applicant table a1 note 3 $335 $375

Table a1 note(s)

Table a1 note 1

The new rate is calculated in accordance with the cumulative percentage increase to the Consumer Price Index for Canada, published by Statistics Canada, for the two previous years (2022 and 2023), rounded to the nearest five dollar.

Return to table a1 note 1 referrer

Table a1 note 2

These applicants are exempt from paying Right of Permanent Residence Fee (normally paid by all permanent resident applicants except dependent children and protected persons). Principal applicants in the "Humanitarian and compassionate" and "Public policy" categories are only exempt under certain circumstances from paying Right of Permanent Residence Fee.

Return to table a1 note 2 referrer

Table a1 note 3

Members of the "Permit holder" class may not include accompanying family members in their applications for permanent residence. Such individuals must submit their own applications as a principal applicant.

Return to table a1 note 3 referrer

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Order 2024-66-01-02 Amending the Non-domestic Substances List

The Minister of the Environment makes the annexed Order 2024-66-01-02 Amending the Non-domestic Substances List under subsection 66(2)footnote a of the Canadian Environmental Protection Act, 1999 footnote b.

Gatineau, March 11, 2024

Steven Guilbeault
Minister of the Environment

Order 2024-66-01-02 Amending the Non-domestic Substances List

Amendments

1 Part I of the Non-domestic Substances List footnote 1 is amended by adding the following in numerical order:

2 Part II of the List is amended by adding the following in numerical order:
19696-4 Alkanediaminium, hydroxy-pentamethyl-9-octadecen-1-yl-, halide
19697-5 Alkanediaminium, hydroxy-pentamethyl-tetradecyl-, halide
19698-6 Alkanediaminium, hexadecyl-hydroxy-pentamethyl-, halide
19699-7 Alkanediaminium, hydroxy-pentamethyl-octadecyl-, halide

Coming into Force

3 This Order comes into force on the day on which it is published in the Canada Gazette.

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Waiver of information requirements for living organisms (subsection 106(9) of the Canadian Environmental Protection Act, 1999)

Whereas any person who proposes to import or manufacture a living organism that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(1) of the Canadian Environmental Protection Act, 1999 (the Act); and

Whereas a person may, pursuant to subsection 106(8) of the Act, request any of the requirements to provide information under subsection 106(1) of the Act to be waived;

Therefore, notice is hereby given, pursuant to subsection 106(9) of the Act, that the Minister of the Environment waived some requirements to provide information in accordance with the following annex pursuant to subsection 106(8) of that Act.

Korian Soumano
Acting Director
Science and Technology Branch
On behalf of the Minister of the Environment

ANNEX

Waiver of information requirements
(Subsection 106(9) of the Canadian Environmental Protection Act, 1999)

Person to whom a waiver was granted Information concerning a living organism in relation to which a waiver was granted
Boehringer-Ingelheim Canada Ltd.
  • Data from tests to determine the effects of the living organism on aquatic plant, invertebrate, and vertebrate species likely to be exposed
  • Data from tests to determine the effects of the living organism on terrestrial plant and invertebrate species likely to be exposed
  • Data from tests of antibiotic susceptibility
CHU de Québec-Université Laval
  • Data from tests to determine the effects of the living organism on aquatic plant, invertebrate, and vertebrate species likely to be exposed
  • Data from tests to determine the effects of the living organism on terrestrial plant, invertebrate, and vertebrate species likely to be exposed
  • Data from tests of antibiotic susceptibility
Emergent BioSolutions Canada Inc.
  • Data from tests to determine the effects of the living organism on aquatic plant, invertebrate, and vertebrate species likely to be exposed
  • Data from tests to determine the effects of the living organism on terrestrial plant and invertebrate species likely to be exposed
Future Fields Data from a test to determine the ecological effects of the living organism (pathogenicity, toxicity or invasiveness) (4) table a2 note a
SIREM
  • Data from tests to determine the effects of the living organism on aquatic plant, invertebrate, and vertebrate species likely to be exposed
  • Data from tests to determine the effects of the living organism on terrestrial plant, invertebrate, and vertebrate species likely to be exposed
  • Data from tests of antibiotic susceptibility
  • Data from tests of pathogenicity that are valid for related living organisms that are pathogenic to humans
Turnstone Biologics, Inc.
  • Data from tests to determine the effects of the living organism on aquatic plant, invertebrate, and vertebrate species likely to be exposed
  • Data from tests to determine the effects of the living organism on terrestrial plant, invertebrate, and vertebrate species likely to be exposed
  • Data from tests of antibiotic susceptibility

Table a2 note(s)

Table a2 note a

The number in brackets indicates the number of times that the information requirement in the second column was waived for the person.

Return to table a2 note a referrer

EXPLANATORY NOTE

The decision to grant a waiver is made on a case-by-case basis by the Minister of the Environment in consultation with the Minister of Health. Every year, approximately 400 regulatory declarations are submitted for chemicals, polymers and living organisms under subsections 81(1), (3) and (4), and 106(1), (3) and (4) of the Canadian Environmental Protection Act, 1999 (the Act) and around 100 waivers are granted yearly for chemicals, polymers and living organisms under subsections 81(8) and 106(8) of the Act.

For more information, please see the waivers web page on the New Substances website.

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Waiver of information requirements for substances (subsection 81(9) of the Canadian Environmental Protection Act, 1999)

Whereas any person who proposes to import or manufacture a substance that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(1) of the Canadian Environmental Protection Act, 1999 (the Act); and

Whereas a person may, pursuant to subsection 81(8) of the Act, request any of the requirements to provide information under subsection 81(1) of the Act to be waived;

Therefore, notice is hereby given, pursuant to subsection 81(9) of the Act, that the Minister of the Environment waived some requirements to provide information pursuant to subsection 81(8) of that Act and in accordance with the following annex.

Korian Soumano
Acting Director
Science and Technology Branch
On behalf of the Minister of the Environment

ANNEX

Waiver of information requirements

(Subsection 81(9) of the Canadian Environmental Protection Act, 1999)
Person to whom a waiver was granted Information concerning a substance in relation to which a waiver was granted
Clariant (Canada) Inc. Data in respect of vapour pressure
Evonik Canada Inc. Data in respect of octanol/water partition coefficient
GSK Consumer Healthcare ULC (Haleon)
  • Data in respect of vapour pressure
  • Data in respect of hydrolysis rate as a function of pH
Incorez Limited Data from an in vivo mammalian mutagenicity test for chromosomal aberrations or gene mutations
Milliken & Company Data in respect of vapour pressure
Phillips 66 Canada Ltd. Data in respect of hydrolysis rate as a function of pH

EXPLANATORY NOTE

The decision to grant a waiver is made on a case-by-case basis by the Minister of the Environment in consultation with the Minister of Health. Every year, approximately 400 regulatory declarations are submitted for chemicals, polymers and living organisms under subsections 81(1), (3) and (4), and 106(1), (3) and (4) of the Canadian Environmental Protection Act, 1999 (the Act) and around 100 waivers are granted yearly for chemicals, polymers and living organisms under subsections 81(8) and 106(8) of the Act.

For more information, please see the waivers web page on the New Substances website.

DEPARTMENT OF THE ENVIRONMENT DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Publication of final decision after assessment of thallium and its compounds, including those specified on the Domestic Substances List and those identified for further consideration following prioritization of the Revised In Commerce List (section 77 of the Canadian Environmental Protection Act, 1999)

Whereas a summary of the assessment conducted on thallium and its compounds pursuant to paragraphs 68(b) and (c) of the Act is annexed hereby;

Whereas 201TlCl is a substance identified for further consideration following prioritization of the Revised In Commerce List;

And whereas it is concluded that thallium and its compounds meet one or more of the criteria set out in section 64 of the Act,

Notice is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to recommend to Her Excellency the Governor in Council that these substances be added to Part 2 of Schedule 1 to the Act.

Notice is furthermore given that the ministers have released a proposed risk management approach document for thallium and its compounds on the Canada.ca (Chemical substances) website to continue discussions with stakeholders on the manner in which the ministers intend to develop a proposed regulation or instrument respecting preventive or control actions in relation to the substances.

Public comment period on the proposed risk management approach

Any person may, within 60 days after publication of the proposed risk management approach document, file with the Minister of the Environment written comments on the proposed risk management approach document. More information regarding the scientific considerations may be obtained from the Canada.ca (Chemical substances) website. All comments must cite the Canada Gazette, Part I, and the date of publication of this notice, and be addressed to the Executive Director, Substance Prioritization, Assessment and Coordination Division, Department of the Environment, Gatineau, Quebec K1A 0H3, by email to substances@ec.gc.ca, or by using the online reporting system available through Environment and Climate Change Canada’s Single Window.

In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.

Steven Guilbeault
Minister of the Environment

Mark Holland
Minister of Health

ANNEX

Summary of the assessment of thallium and its compounds

Pursuant to section 68 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of the Environment and the Minister of Health have conducted an assessment of thallium and its compounds. The scope of this assessment covers the thallium moiety and considers all thallium-containing substances that may release thallium, as well as thallium in its elemental form and thallium released to the environment in dissolved, solid, or particulate forms.

The Chemical Abstracts Service Registry Numbers (CAS RNsfootnote 2), the Domestic Substances List (DSL) or Revised In Commerce List (R-ICL) names and the common names of these five substances identified as initial thallium priorities are listed in the table below.

Thallium-containing substances identified as priorities for assessment
CAS RN DSL or R-ICL name Common name
7440-28-0 Thallium Thallium
563-68-8 Acetic acid, thallium(1+) salt Thallium(I) acetate
7791-12-0 Thallium chloride Thallium chloride
10031-59-1 table a4 note a Sulfuric acid, thallium(1+) salt (1:?) Thallium(I) sulfate
55172-29-7 table a4 note b Thallium chloride (201TlCl) 201TlCl

Table a4 note(s)

Table a4 note a

This substance was removed from the R-ICL in 2022 as it was determined not to have commercial activity in Canada for use in products under the Food and Drugs Act.

Return to table a4 note a referrer

Table a4 note b

This substance is on the Revised In Commerce List (R-ICL).

Return to table a4 note b referrer

Thallium exists in the earth’s crust at an average concentration of 0.7 parts per million. It is typically associated with the sulfide ores of various metals, including zinc, copper, iron, and lead, and is also present in coal. Thallium is present in many natural minerals as well as in meteorites, volcanic rocks, and plants, and in trace amounts in most living organisms.

Anthropogenic sources of thallium are primarily associated with the incidental production and releases of residues or by-products from various industrial activities, such as smelting and refining processes, metal mining, and fly ashes from coal-fired electrical power generation. Thallium production was estimated to be below 8 tonnes globally in 2020.

Thallium(I) acetate, thallium chloride, and thallium(I) sulfate were included in a survey issued pursuant to section 71 of CEPA. In 2011, between 100 kg and 1 000 kg of thallium chloride were manufactured in Canada; no information above the reporting threshold of 100 kg was received with respect to the import of this substance in Canada. No information above the reporting threshold of 100 kg was received for the other two substances. According to the Canadian International Merchandise Trade (CIMT) database, less than 50 kg per year of thallium were imported into Canada between 2017 and 2020.

Internationally, the main uses of thallium substances include use in fibre (optical) glasses to increase refractive index and density, in semiconductor material, in infrared radiation detection and transmission equipment, in photoelectric cells, in mercury-thallium alloys for low-temperature measurements, in crystalline filters for light diffraction in acoustic-optical measuring devices, in high-density liquid for sink-float separation of minerals, as an activator in gamma radiation detection devices (scintillometers), and as intermediates in chemical production. Other uses include use in mercury arc lamps, alloys with other metals, jewellery, fireworks, and pigments and dyes. In Canada, thallium is also used in products available to consumers, for example, as a radiopharmaceutical in human drug products and as a medicinal ingredient in homeopathic licensed natural health products. Thallium may also be used as a component in the manufacture of food packaging materials.

Thallium exists in two oxidation states in the aquatic environment: monovalent thallous Tl(I) [i.e. Tl+] and trivalent thallic Tl(III) [i.e. Tl3+]. The highly soluble and weakly reactive Tl(I) ion is the more bioavailable thallium species in both aquatic and terrestrial environments. The precipitation of inert Tl(OH)3 may be an effective mechanism for removing thallium from water. However, thallium may be remobilized from sediments and enter the water column under anoxic conditions, where Tl(III) will be reduced to Tl(I). Therefore, Tl(I) is the focus of this assessment.

Thallium is considered to be persistent because it cannot be degraded further in the environment, although it can transform into different chemical species or partition among different phases within an environmental medium. Thallium is not an essential element for organisms. Organisms exposed to thallium readily take up thallium either through direct contact with environmental media (dermal or respiratory exposure) or by food ingestion. Elevated thallium concentrations have been observed in organisms living near sources of releases (e.g. smelters). Thallium may also accumulate in aquatic and soil-dwelling organisms, as well as in plants. Owing to the very limited and contradictory data presently available, no conclusions can be drawn with certainty regarding the potential for thallium to biomagnify in aquatic and terrestrial food chains.

At very low concentrations, thallium causes mortality as well as growth and reproductive effects in aquatic and terrestrial organisms. The chronic predicted no-effect concentrations (PNECs) for thallium for aquatic organisms were derived from ecotoxicity studies. The soil PNEC was adopted from the 1999 Canadian Council of Ministers of the Environment (CCME) guideline, as current thallium soil toxicity data indicate that this PNEC is protective of soil-dwelling organisms and plants in the Canadian environment.

The potential for cumulative effects was considered in this assessment by examining cumulative exposure to the moiety of thallium. A weight-of-evidence approach was used to determine the potential for ecological harm in Canada. Risk quotient (RQ) analyses were performed by comparing predicted environmental concentrations (PECs) with PNECs. Thallium releases to the aquatic compartment from metal mining, base metals smelting, coal-fired power generation facilities, and wastewater treatment systems were analyzed. The PECs for the metal mining and base metals smelting sectors consisted primarily of measured thallium concentrations in the receiving environments (i.e. exposure areas) and corresponding reference areas. The analysis indicates that thallium releases from most facilities are limited, but there is a potential for harm to the aquatic environment as a result of thallium release from a small number of facilities in these sectors. Prior to the year 2000, one facility in the coal-powered energy sector had a high RQ, owing to releases of thallium from its lagoon effluents; however, the latest release and effluent concentration data from the National Pollutant Release Inventory (NPRI) showed a low potential for ecological risk from the facility. RQs for thallium discharged to surface water from wastewater treatment systems or through the application of biosolids to agricultural lands from wastewater treatment systems are low.

Considering all available lines of evidence presented in this assessment, it is concluded that there is a risk of harm to the environment from thallium and its compounds. It is concluded that thallium and its compounds meet the criteria under paragraph 64(a) of CEPA as they are entering or may enter the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity. However, it is concluded that thallium and its compounds do not meet the criteria under paragraph 64(b) of CEPA as they are not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger to the environment on which life depends.

For the assessment of risk to human health, thallium and its compounds were evaluated using Biomonitoring-based Approach 2, which compares human biomonitoring data (as a measure of exposure) against biomonitoring guidance values (health-based exposure guidance values) to assess if substances are of low concern for human health. Thallium concentrations were measured in the urine of North Americans as part of the Canadian Health Measures Survey (CHMS) and the National Health and Nutrition Examination Survey (NHANES) in the United States, as well as in studies targeting specific subpopulations, such as a First Nations Gwich’in community in Old Crow, Yukon, First Nations communities in the Northwest Territories’ Mackenzie Valley, and the Inuit population in Nunavik, Quebec. A human biomonitoring guidance value (HBM-I) established by the German Environment Agency is considered to be protective of adverse health effects of thallium in humans. Median and 95th percentile urinary thallium concentrations in Canadians (3 to 79 years) of 0.21 µg/g and 0.55 µg/g creatinine were lower than the HBM-I value of 6.4 µg/g creatinine. In addition, urinary thallium concentrations in certain Indigenous communities were below the HBM-I value. Therefore, thallium and its compounds are considered to be of low concern to human health at current levels of exposure.

The human health assessment took into consideration those groups of individuals within the Canadian population who, due to greater susceptibility or greater exposure, may be more vulnerable to experiencing adverse health effects. For thallium and its compounds, Canadian human biomonitoring data in children as well as in pregnancies and specific Indigenous communities were used to inform consideration of these populations and take them into account in the risk assessment outcomes.

Considering all the information presented in this assessment, it is concluded that thallium and its compounds do not meet the criteria under paragraph 64(c) of CEPA as they are not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.

Overall conclusion

It is concluded that thallium and its compounds meet one or more of the criteria set out in section 64 of CEPA.

It is also determined that thallium and its compounds meet the persistence criteria but not the bioaccumulation criteria as set out in the Persistence and Bioaccumulation Regulations of CEPA.

The assessment and the risk management approach document for these substances are available on the Canada.ca (Chemical substances) website.

DEPARTMENT OF HEALTH

DEPARTMENT OF HEALTH ACT

Notice amending Health Canada’s National Dosimetry Services Products, Services and Fees Schedule

Health Canada’s National Dosimetry Services (NDS) provide radiation monitoring services to Canadians who are exposed to radiation in their work environment. The NDS, operating on a cost-recovery basis, provide commercial dosimetry services to over 100 000 individuals working in over 12 500 organizations.

The Minister of Health, under the authority of the Department of Health Act, hereby amends the fees that are payable for the provision of Health Canada’s NDS beginning April 1, 2024. The objective of the change to the Products, Services and Fees Schedule is to bring revenues in line with expenses, while enabling the NDS to provide affordable and high quality dosimetry services to all clients. The NDS have not increased their fees since 2021.

NOTES AND FEE DESCRIPTIONS

A number of components to the dosimetry services will be billed regularly. These fees include the annual support fee, the shipping and handling fee, and the processing fee.

Table 1: Core fees
Name Frequency of billing Description
Annual support fee

Once annually

Will be included in the Account Activity Report between April and June.

 Fee for account management and client services support Companies with five or more groups receive the multi-group discount.
Shipping and handling fee Each shipment Fee for preparation and shipment (includes return postage)
Processing fee Each shipment Fee to read, analyze, test and calibrate each dosimeter (includes issuance of exposure reports and submission of dose data to the National Dose Registry [NDR])

Other fees are payable only if additional services are requested or if a dosimeter is overdue, late, lost or damaged.

Table 2: Additional fees and credits
Nom Description
Ad hoc dosimeter request fee This fee applies when additional dosimeters are requested outside of the regularly scheduled shipment (e.g. in the middle of the wearing period).
Overdue/late fees Dosimeters must be returned within an allotted time frame or clients risk being billed overdue or late fees. An "overdue" fee will apply for any dosimeters not received within three months following the end of the wearing period. A supplementary "late" fee will apply for any dosimeters not returned within an additional three months (six months total).
Lost/damaged fees The lost fee is incurred when a client informs the NDS that a dosimeter cannot be found. The damaged fee is incurred when a dosimeter is returned by a client and cannot be read and/or reused due to misuse or tampering.
Credits Clients who have been billed for overdue, late or lost dosimeters and subsequently return the dosimeters will receive a partial credit (excludes discontinued products).

NATIONAL DOSIMETRY SERVICES PRODUCTS, SERVICES AND FEES SCHEDULE

Fees are subject to change without notice in accordance with the consumer price index. Notice will be provided for all other changes.

The fees shown below are effective April 1, 2024:

Table 3: Processing fees (per dosimeter) — Dosimeter reading, analysis, testing and calibration

Number of dosimeters required

Per shipment

InLight dosimeter

Fee per quarterly wearing period  table b3 note a

InLight dosimeter

Fee per semi-monthly/monthly wearing period

Ring dosimeter

Fee per monthly/quarterly wearing period

Neutron dosimeter

Fee per monthly/quarterly wearing period
1–2 $12.25 $10.50 $12.50 $17.50
3–4 $11.25 $8.50 $11.75 $16.50
5–6 $10.25 $7.75 $10.75 $15.50
7–8 $9.25 $7.50 $9.75 $14.50
9–14 $8.25 $7.25 $8.75 $13.50
15–22 $7.75 $7.00 $8.50 $12.50
23–34 $7.25 $6.75 $8.00 $11.25
35–49 $7.00 $6.50 $7.50 $10.75
50+ $6.00 $6.00 $6.50 $10.25

Table b3 note(s)

Table b3 note a

Dosimeters can be worn for different lengths of time (wearing periods). The NDS offer quarterly (4 shipments per year), monthly (12 shipments per year) and semi-monthly (24 shipments per year) wearing periods.

Return to table b3 note a referrer
Table 4: Additional services
Description Fee
Ad hoc dosimeter request — add-on (per shipment) $75.00
Priority processing request (per request) $110.00
Electronic personal dosimeter rental (per nine months) $322.50
Electronic personal dosimeter rental with beta module (per nine months) $375.00
Specialized consultation (per hour) $125.00
Customized reporting (per hour) $70.00
NDR dose modifications (per hour) $75.00
Reprinting reports (per report) $25.00
Table 5: Late/lost/damaged fees (per dosimeter)
Description Fee
Overdue dosimeter (three months after wearing period ends) $48.50
Late dosimeter (six months after wearing period ends) $48.50
Lost/damaged dosimeter $80.00
Damaged electronic personal dosimeter $430.00
Table 6: Credits
Description Fee
Upon returning an overdue dosimeter $24.00
Upon returning a dosimeter identified as late or lost $40.00

CONTACT

Additional information on the Products, Services and Fee Schedule is available through Client Services, at 1‑800‑261‑6689 (telephone), 1‑800‑252‑6272 (fax) or NDS-SND@hc-sc.gc.ca (email).

DEPARTMENT OF TRANSPORT

CANADA TRANSPORTATION ACT

Levy on shipments of crude oil by rail

Pursuant to subsection 155.4(4)footnote c of the Canada Transportation Act (the Act), the amount of the levy in respect of payments into the Fund for Railway Accidents Involving Designated Goods required by subsection 155.7(1)footnote c of the Act is $2.07 per tonne during the year commencing April 1, 2024.

March 20, 2024

Pablo Rodriguez, P.C., M.P.
Minister of Transport

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

BANK ACT

Schedules I, II and III

Notice is hereby given, pursuant to subsections 14(3) and 14.1(3) of the Bank Act, that Schedules I, II and III, as amended, were as shown below as at December 31, 2023.

SCHEDULE I

(Section 14)

As at December 31, 2023
Name of Bank Head Office
B2B Bank Ontario
Bank of Montreal Quebec
Bank of Nova Scotia (The) Nova Scotia
Bridgewater Bank Alberta
Caisse populaire acadienne ltée New Brunswick
Canadian Imperial Bank of Commerce Ontario
Canadian Tire Bank Ontario
Canadian Western Bank Alberta
Coast Capital Savings Federal Credit Union British Columbia
Concentra Bank Saskatchewan
CS Alterna Bank Ontario
Digital Commerce Bank Alberta
Equitable Bank Ontario
Exchange Bank of Canada Ontario
Fairstone Bank of Canada Ontario
First Nations Bank of Canada Saskatchewan
General Bank of Canada Alberta
Haventree Bank Ontario
Home Bank Ontario
HomeEquity Bank Ontario
Innovation Federal Credit Union Saskatchewan
Laurentian Bank of Canada Quebec
Manulife Bank of Canada Ontario
Motus Bank Ontario
National Bank of Canada Quebec
Peoples Bank of Canada British Columbia
President’s Choice Bank Ontario
RFA Bank of Canada Ontario
Rogers Bank Ontario
Royal Bank of Canada Quebec
Tangerine Bank Ontario
Toronto-Dominion Bank (The) Ontario
Vancity Community Investment Bank British Columbia
VersaBank Ontario
Wealth One Bank of Canada Ontario

SCHEDULE II

(Section 14)

As at December 31, 2023
Name of Bank Head Office
Amex Bank of Canada Ontario
Bank of China (Canada) Ontario
Cidel Bank Canada Ontario
Citco Bank Canada Ontario
Citibank Canada Ontario
CTBC Bank Corp. (Canada) British Columbia
Habib Canadian Bank Ontario
HSBC Bank Canada British Columbia
ICICI Bank Canada Ontario
Industrial and Commercial Bank of China (Canada) Ontario
J.P. Morgan Bank Canada Ontario
KEB Hana Bank Canada Ontario
SBI Canada Bank Ontario
Shinhan Bank Canada Ontario
UBS Bank (Canada) Ontario

SCHEDULE III

(Section 14.1)

As at December 31, 2023
Name of Authorized Foreign Bank (FB) Name under which FB is permitted to carry on business in Canada Type of Foreign Bank Branch (FBB) table b9 note * Principal Office
Bank of America, National Association Bank of America, National Association Full-service Ontario
Bank of China Limited Bank of China, Toronto Branch Full-service Ontario
Bank of New York Mellon (The) Bank of New York Mellon (The) Full-service Ontario
Barclays Bank PLC Barclays Bank PLC, Canada Branch Full-service Ontario
BNP Paribas BNP Paribas Full-service Quebec
Capital One, National Association Capital One Bank (Canada Branch) Full-service Ontario
China Construction Bank China Construction Bank Toronto Branch Full-service Ontario
Citibank, N.A. Citibank, N.A. Full-service Ontario
Comerica Bank Comerica Bank Full-service Ontario
Coöperatieve Rabobank U.A. Rabobank Canada Full-service Ontario
Crédit Agricole Corporate and Investment Bank Crédit Agricole Corporate and Investment Bank (Canada Branch) Lending Quebec
Credit Suisse AG Credit Suisse AG, Toronto Branch Lending Ontario
Deutsche Bank AG Deutsche Bank AG Full-service Ontario
Fifth Third Bank, National Association Fifth Third Bank, National Association Full-service Ontario
First Commercial Bank First Commercial Bank Full-service British Columbia
JPMorgan Chase Bank, National Association JPMorgan Chase Bank, National Association Full-service Ontario
M&T Bank M&T Bank Full-service Ontario
Maple Bank GmbH Maple Bank Full-service Ontario
Mega International Commercial
Bank Co., Ltd.		 Mega International Commercial
Bank Co., Ltd.		 Full-service Ontario
Mizuho Bank, Ltd. Mizuho Bank, Ltd., Canada Branch Full-service Ontario
MUFG Bank, Ltd. MUFG Bank, Ltd., Canada Branch Full-service Ontario
Natixis Natixis Canada Branch Lending Quebec
Northern Trust Company (The) Northern Trust Company, Canada Branch (The) Full-service Ontario
PNC Bank, National Association PNC Bank Canada Branch Full-service Ontario
Silicon Valley Bank Silicon Valley Bank Lending Ontario
Société Générale Société Générale (Canada Branch) Full-service Quebec
State Street Bank and Trust Company State Street Full-service Ontario
Sumitomo Mitsui Banking Corporation Sumitomo Mitsui Banking Corporation, Canada Branch Full-service Ontario
U.S. Bank National Association U.S. Bank National Association Full-service Ontario
United Overseas Bank Limited United Overseas Bank Limited Full-service British Columbia
Wells Fargo Bank, National Association Wells Fargo Bank, National Association, Canadian Branch Full-service Ontario

Table b9 note(s)

Table b9 note *

An FBB, whose order is subject to the restrictions and requirements referred to in subsection 524(2) of the Bank Act, is referred to as a "lending" branch.

Return to table b9 note * referrer

March 22, 2024

Peter Routledge
Superintendent of Financial Institutions

PRIVY COUNCIL OFFICE

Appointment opportunities

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. The Government of Canada has implemented an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous peoples and minority groups are properly represented in positions of leadership. We continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

We are equally committed to providing a healthy workplace that supports one’s dignity, self-esteem and the ability to work to one’s full potential. With this in mind, all appointees will be expected to take steps to promote and maintain a healthy, respectful and harassment-free work environment.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council appointments website.

Governor in Council appointment opportunities
Position Organization Closing date
Director Bank of Canada  
Director Canada Foundation for Innovation  
Director Canada Foundation for Sustainable Development Technology  
Director Canada Infrastructure Bank  
Chairperson Canada Mortgage and Housing Corporation  
Director Canada Mortgage and Housing Corporation  
President Canada Mortgage and Housing Corporation  
Chairperson Canadian Accessibility Standards Development Organization  
Director Canadian Air Transport Security Authority  
President Canadian Broadcasting Corporation  
Director Canadian Centre on Substance Abuse  
Director Canadian Commercial Corporation  
Commissioner Canadian Energy Regulator  
Director Canadian Energy Regulator  
Chief Commissioner Canadian Grain Commission  
Chief Commissioner Canadian Human Rights Commission  
Member Canadian Institutes of Health Research  
President Canadian Institutes of Health Research  
Chairperson Canadian Museum for Human Rights  
President Canadian Nuclear Safety Commission  
Director Canadian Race Relations Foundation  
Director Canadian Tourism Commission  
Chairperson Canadian Transportation Accident Investigation and Safety Board  
Member Copyright Board  
Director Export Development Canada  
Commissioner Financial Consumer Agency of Canada  
Commissioner First Nations Tax Commission  
Director (Federal) Halifax Port Authority  
Deputy Chairperson and Member, Refugee Appeal Division Immigration and Refugee Board  
Member Independent Advisory Board on Eligibility for Journalism Tax Measures  
Vice-Chairperson Independent Advisory Board on Eligibility for Journalism Tax Measures  
Member International Pacific Halibut Commission  
Chairperson Laurentian Pilotage Authority  
Commissioner Law Commission of Canada  
Parliamentary Librarian Library of Parliament  
Chairperson National Advisory Council on Poverty  
Member (Children’s Issues) National Advisory Council on Poverty  
Member National Arts Centre Corporation  
Chairperson National Gallery of Canada  
Chairperson National Seniors Council  
Member National Seniors Council  
Member Natural Sciences and Engineering Research Council  
Canadian Representative North Atlantic Salmon Conservation Organization  
Director of Public Prosecutions Office of the Director of Public Prosecutions  
Member Parole Board of Canada April 16, 2024
Administrator Ship-source Oil Pollution Fund and Fund for Railway Accidents Involving Designated Goods  
Member Social Sciences and Humanities Research Council  
Chief Statistician Statistics Canada  
Chairperson Telefilm Canada  
Member Telefilm Canada  
Director VIA Rail Canada Inc.